Ole Jannik Bjerrum

Ole Jannik Bjerrum

Professor, emeritus


  1. 2018
  2. Published

    The β-lactam clavulanic acid mediates glutamate transport-sensitive pain relief in a rat model of neuropathic pain

    Kristensen, P. J., Gegelashvili, G., Munro, G., Heegaard, Anne-Marie & Bjerrum, Ole Jannik, Feb 2018, In: European Journal of Pain. 22, 2, p. 282-294

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Heterozygous mutations in GTP-cyclohydrolase-1 reduce BH4 biosynthesis but not pain sensitivity

    Nasser, A., Møller, A. T., Hellmund, V., Thorborg, S. S., Jespersgaard, C., Bjerrum, Ole Jannik, Dupontd, E., Nachman, G., Lykkesfeldt, Jens, Jensen, T. S. & Møller, L. B., 2018, In: Pain. 159, 6, p. 1012-1024 13 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. 2017
  5. Published

    Vendor-derived differences in injury-induced pain phenotype and pharmacology of Sprague-Dawley rats: Does it matter?

    Kristensen, P. J., Heegaard, Anne-Marie, Hestehave, Sara, Jeggo, R. D., Bjerrum, Ole Jannik & Munro, G., Apr 2017, In: European Journal of Pain. 21, 4, p. 692-704 13 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    From Face-to-fase training to blended learning in the postgraduate program SafeSciMet - a case study

    Bjerrum, Ole Jannik, Vos, C., Dragovic, S., Jochimsen, M., Dirac, J., Foth, H. & Wiese, J., 2017, In: European Journal of Pharmaceutical Sciences. 96, p. III-VIII 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    Glutamate Transport System as a Novel Therapeutic Target in Chronic Pain: Molecular Mechanisms and Pharmacology

    Gegelashvili, G. & Bjerrum, Ole Jannik, 2017, Glial Amino Acid Transporters. Springer, Vol. 16. p. 225-253 29 p. (Advances in Neurobiology).

    Research output: Chapter in Book/Report/Conference proceedingBook chapterResearchpeer-review

  8. 2016
  9. Published

    A Paradigm Shift Towards Patient Involvement in Medicines Development and Regulatory Science: Workshop Proceedings and Commentary

    Borup, G., Bach, K. F., Schmiegelow, M., Kildemoes, H. W., Bjerrum, Ole Jannik & Westergaard, N., May 2016, In: Therapeutic Innovation & Regulatory Science. 50, 3, p. 304-311 8 p.

    Research output: Contribution to journalComment/debateResearchpeer-review

  10. 2015
  11. Published

    An analysis of the fixed-dose combinations authorized by the European Union, 2009-14: A Focus on benefit-risk and clinial development condition

    Sawicki-Wrzask, D., Thomsen, M. & Bjerrum, Ole Jannik, 2015, In: Therapeutic Innovation & Regulatory Science. 49, 4, p. 553-559 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  12. Published

    High-affinity Glutamate Transporters in Pain: An Emerging and Therapeutic Target

    Gegelashvili, G. & Bjerrum, Ole Jannik, 2015, In: Journal of Neurochemistry. 6, p. 712-30 18 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  13. Published

    Intraplantar injection of tetrahydrobiopterin induces nociception in mice

    Nasser, A., Ali, S., Wilsbech, S., Bjerrum, Ole Jannik & Birk Møller, L., 2015, In: Neuroscience Letters. 584, p. 247-252 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  14. Published

    The wider use of fixed-dose combinations emphasizes the need for a global approach to regulatory guideline development

    Gautam, Y., Bjerrum, Ole Jannik & Schmiegelow, M., 2015, In: Therapeutic Innovation & Regulatory Science. 49, 1, p. 197-204 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1 2 3 4 5 6 7 8 ...10 Next

ID: 1302721